Davide Nilo
Overview
Explore the profile of Davide Nilo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caturano A, Erul E, Nilo R, Nilo D, Russo V, Rinaldi L, et al.
Mol Cell Biochem
. 2025 Mar;
PMID: 40089612
The association between insulin resistance (IR), type 2 diabetes mellitus (T2DM), and cancer is increasingly recognized and poses an escalating global health challenge, as the incidence of these conditions continues...
2.
Cinque F, Nilo D, Gezzi A, De Gregorio F, Clerici B
Intern Emerg Med
. 2025 Mar;
PMID: 40029567
No abstract available.
3.
Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Lorenzo G, et al.
Antioxidants (Basel)
. 2025 Jan;
14(1).
PMID: 39857406
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly increases the risk of cardiovascular disease, which is the leading cause of morbidity and mortality among diabetic patients....
4.
Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D, et al.
Biomolecules
. 2024 Nov;
14(11).
PMID: 39595570
Chronic kidney disease (CKD) represents a significant global health challenge, affecting millions of individuals and leading to substantial morbidity and mortality. This review aims to explore the epidemiology, cardiovascular complications,...
5.
Caturano A, Galiero R, Rocco M, Tagliaferri G, Piacevole A, Nilo D, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335551
Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic disorder characterized by insulin resistance and progressive beta cell dysfunction, presenting substantial global health and economic challenges. This review explores...
6.
Caturano A, Nilo D, Nilo R, Russo V, Monda M, Rinaldi L, et al.
J Cardiovasc Pharmacol
. 2024 Sep;
84(5):490-492.
PMID: 39259246
No abstract available.
7.
Caturano A, Nilo R, Nilo D, Russo V, Santonastaso E, Galiero R, et al.
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065795
Diabetes mellitus, which comprises a group of metabolic disorders affecting carbohydrate metabolism, is characterized by improper glucose utilization and excessive production, leading to hyperglycemia. The global prevalence of diabetes is...
8.
Caturano A, Nilo D, Russo V, Galiero R, Monda M, Marfella R, et al.
J Cardiovasc Pharmacol
. 2024 Feb;
83(4):308-310.
PMID: 38324028
No abstract available.